Cummulative toxicities on lipid profile and glucose following administration of anti-epileptic, anti-hypertensive, anti-diabetic and anti-arrhythmic drugs

Pakistan Journal of Pharmaceutical Sciences

Volumn 24, Issue 1, 2011, Pages 47-51

  Feroz, Zeeshan ^a   Khan, Rafeeq Alam ^a   Afroz, Syeda ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Cumulative toxicities; Glucose; Lipid profile

Indexed keywords

AMIODARONE; CAPTOPRIL; GLIBENCLAMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOSARTAN POTASSIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXCARBAZEPINE; TRIACYLGLYCEROL; VERAPAMIL;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIARRHEA; EDEMA; FEMALE; HAIR LOSS; MALE; NONHUMAN; ULCER;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; DRUG COMBINATIONS; DRUG INTERACTIONS; FEMALE; HYPOGLYCEMIC AGENTS; LIPID METABOLISM; LIPIDS; MALE; RABBITS;

EID: 78651394271     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Aghasadeghi K, Zarei-Nezhad M, Keshavarzi A and Mehrabani D (2008). The prevalence of coronary risk factors in Iranian lor migrating tribe. Arch. Iran. Med, 11(3): 322-325.
2. Barham D and Trinder P (1972). The analyst, interdisciplinary detection science. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst, 97: 142-145.
3. Brown MS (1984). How LDL receptors influence cholesterol and atherosclerosis. Sci. Am, 251: 52-60.
4. Cullen G, Kelly E and Murray FE (2006). Patients' knowledge of adverse reactions to current medications. Brit. J. Clin. Pharmaco, 62(2): 232-236.
5. Dietschy JM (1998). Dietary fatty acids and the regulation of plasma low density lipoprotein cholesterol concentrations. J. Nutr, 128: 444S-448S.
6. Durrington P (2003). Dyslipidaemia. Lancet, 362(9385): 717-731.
7. Faulx M and Francis G (2008). Adverse drug reactions in patients with cardiovascular disease. Curr. Prob. Cardiology, 33(12): 703-768.
8. Feroz Z, Khan RA, Mirza T and Afroz S (2010). Adverse effects of cumulative administration of anti-epileptic, anti-hypertensive, anti-diabetic and anti-arrhythmic drugs on renal and cardiac parameters. Int. J. Med. Res, 1(1): 39-47.
9. Friedewald WT, Levy RI and Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem, 18: 499-502.
10. Gordon T, Castelli WP, Hjortland MC, Kannel WB and Dawber TR (1977). High density lipoprotein as a protective factor against coronary heart disease; The Framingham study. Am. J. Med, 62: 707-714.
11. Haffner SM, Lehto S, Ronnemaa T, Pyorala K and Laakso M (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New. Engl. J. Med., 339: 229-234.
12. Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, Cowan LD, Gray RS, Welty TK, Go OT and Howard WJ (2000). LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL. Arterioscler. Throm. Vas, 20: 830-835.
13. Koh Y, Moideen FB and Li SC (2005). Drug-related problems in hospitalized patients on polypharmacy: The influence of age and gender. Ther. Clin. Risk. Manag, 1(1): 39-48.
14. Lazarou J, Pomeranz BH and Corey PN (1998). Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. J. Am. Med. Ass., 279: 1200-1205.
15. Mahomed I.M and Ojewole J.A (2003). Hypoglycemic effect of Hypoxis hemerocallidea corm (African potato) aqueous extract in rats. Method. Find. Exp. Clin., 25(8): 617-623.
16. Mallet L, Spinewine A and Huang A (2007). The challenge of managing drug interactions in elderly people. The Lancet, 370(9582): 185-191.
17. Oshikoya KA and Awobusuyi JO (2009). Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol., 9: 14.
18. Pleuvry BJ (2005). Pharmacodynamic and pharmacokinetic drug interactions. Anaesth. Intens. Care, 6(4): 129-133.
19. Rabinovitz H, Berkowitch M, Golik A and Shani S (2001). Adverse drug reactions definitions and terminology. Harefuah, 140(12): 1181-1186.
20. Routledge P.A, O'Mahony MS and Woodhouse KW (2004). Adverse drug reactions in elderly patients. Brit. J. Clin. Pharmaco., 57(2): 121-126.
21. Schlienger RG (2000). Management of adverse drug effects. Ther. Umsch., 57(9): 584-590.
22. Trinder P (1969). Enzymatic calorimetric determination of triglycerides by GOP-PAP method. Ann. Clin. Biochem, 6: 24-27.